S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|OPKO's Long-Acting Clotting Factor VIIa-CTP Receives Positive Opinion For Three Orphan Drug Designations in Europe|
|Concert Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for CTP-499|
|Concert Pharmaceuticals Announces FDA Lifts Partial Clinical Hold for CTP-354, A Novel Drug Candidate for Spasticity|
|Data Supporting Once-Weekly Dosing of hGH-CTP in Growth Hormone Deficient Pediatric Population to be Presented as a Late Breaking Presentation at the European Society of Paediatric Endocrinology Conference|
|OPKO to Hold Conference Call to Discuss Six Month Data from Phase 2 hGH-CTP Trial|
|OPKO Granted Patent from European Patent Office for Lagova™|
|Strong Data from Lagova™ Phase II Clinical Study Presented during Webcast|
|Concert Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Company Update|
|OPKO Announces Second Quarter Operating and Financial Results|
|Kodak Celebrates Manufacturing Milestone with the Installation of 20,000th KODAK SQUARESPOT Thermal Imaging Head (2014/7/29)|
Click above to view more mutual fund data and stats for ctp - CTPartners Executive Search Inc.